Cr III (LD)(Urd)(H 2 O) 4 ](NO 3 ) 2 Á 3H 2 O (LD ¼ Levodopa; Urd ¼ uridine) was prepared and characterized. The product of the oxidation reaction was examined using HPLC. Kinetics of the oxidation of [Cr III (LD)(Urd)(H 2 O) 4 ] 2þ with N-bromosuccinimide (NBS) in an aqueous solution was studied spectrophotometrically, with 1.0-5.0 Â 10 À4 mol dm À3 complex, 0.5-5.0 Â 10 À2 mol dm À3 NBS, 0.2-0.3 mol dm À3 ionic strength (I), and 30-50 C. The reaction is first order with respect to [Cr III ] and [NBS], decreases as pH increases in the range 5.46-6.54 and increases with the addition of sodium dodecyl sulfate (SDS, 0.0-1.0 Â 10 À3 mol dm À3 ). Activation parameters including enthalpy, DH*, and entropy, DS*, were calculated. The experimental rate law is consistent with a mechanism in which the protonated species is more reactive than its conjugate base. It is assumed that the two-step one-electron transfer takes place via an inner-sphere mechanism. A mechanism for this reaction is proposed and supported by an excellent isokinetic relationship between DH* and DS* for some Cr III complexes. Formation of [Cr III (LD)(Urd)(H 2 O) 4 ] 2þ in vivo probably occurs with patients who administer the anti-Parkinson drug (Levodopa), since Cr III is a natural food element. This work provides an opportunity to identify the nature of such interactions in vivo similar to that in vitro.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.